Sheel Biotech IPO Date, Review, Price, Allotment Details
The Sheel Biotech IPO will open on September 30, 2025, and close on October 3, 2025. This is a Fixed Price Issue, through which the company intends to raise around ₹34.02 crores, comprising a fresh issue of ₹34.02 crores and an offer for sale of up to [.] equity shares, each with a face value of ₹10.
The shares are priced between ₹59 and ₹63 per share, with 35% reserved for retail investors, 50% for qualified institutional buyers (QIBs), and 15% for high net worth individuals (HNIs). The allotment is expected to be finalized by October 6, 2025, and the shares are scheduled for listing on the NSE on October 8, 2025.
On the financial front, the company posted a revenue of ₹92.55 crores in 2024, up from ₹80.19 crores in 2023, while net profit rose to ₹10.51 crores in 2024 from ₹5.08 crores in 2023. Given these strong financials, the IPO is seen as a potential long-term investment opportunity.
Sheel Biotech IPO Details
IPO Open Date September 30, 2025 IPO Close Date October 3, 2025 Face Value ₹10 Per Equity Share IPO Price Band ₹59 to ₹63 Per Share Issue Size Approx ₹34.02 Crores Fresh Issue Approx ₹34.02 Crores Issue Type Fixed Price Issue IPO Listing NSE SME DRHP Draft Prospectus 
Sheel Biotech IPO Market Lot
The Sheel Biotech IPO minimum market lot is 4,000 shares, with an application amount of ₹ 2,52,000.
Application Lot Size Shares Amount Retail Minimum 2 4,000 ₹2,52,000 Retail Maximum 2 4,000 ₹2,52,000 S-HNI Minimum 3 6,000 ₹3,78,000
IPO Reservation
Investor Category Share Offered -% Shares Anchor Investor 15,24,000 Shares 28.22% QIB (Ex. Anchor) 10,26,000 Shares 19.00% NII Shares Offered 7,74,000 Shares 14.33% Retail Shares Offered 18,04,000 Shares 33.41%
Sheel Biotech IPO Anchor Investors
Anchor Bidding Date 2025 Anchor Investors List Shares Offered 15,24,000 Shares Anchor Size 9.60 Cr. lock-in period end date 50% shares (30 Days) November 5, 2025 lock-in period end date 50% shares (90 Days) January 4, 2026
Sheel Biotech IPO Dates
The Sheel Biotech IPO is set to open on September 30, 2025, and close on October 3, 2025. The allotment of shares is scheduled for October 6, 2025, with the IPO expected to be listed on the NSE on October 8, 2025.
IPO Open Date: September 30, 2025 IPO Close Date: October 3, 2025 Basis of Allotment: October 6, 2025 Refunds: October 7, 2025 Credit to Demat Account: October 7, 2025 IPO Listing Date: October 8, 2025 IPO Bidding Cut-off Time: October 3, 2025 – 5 PM
Promoters and Holding Pattern
The promoters of the company are Dr. Satya Narayan Chandak, Mr. Sanjay Chandak, Mr. Divye Chandak, Mrs. Mini Chadha, M/s Satya Narayan Chandak (HUF), M/s Sanjay Chandak (HUF), and M/s Sumeet Chandak (HUF).
Particular Shares % Share Promoter Holding Pre Issue 1,49,52,550 96.99% Promoter Holding Post Issue 2,03,52,550 71.26%
Objects of the Issue & Utilisation of Proceeds
Purpose Crores Capital Expenditure Requirement 9.12 Working Capital Requirement 15.88 General Corporate Purpose –
About Sheel Biotech IPO
Incorporated in November 1991, Sheel Biotech Limited is a multifaceted company engaged in biotechnology, floriculture, greenhouse solutions, and organic projects. The company supplies superior planting materials for fruits, vegetables, field crops, and ornamentals through tissue culture and organic farming. It also designs, manufactures, and maintains greenhouses, provides landscaping services to government and private sectors, and supports farmers through training and FPO management. With ISO 9001:2015, 14001:2015, and 45001:2018 certifications, Sheel Biotech upholds high standards of quality, environmental care, and workplace safety. Its R&D laboratory is recognized by the Department of Biotechnology (DBT) and the Department of Science and Technology (DST), underscoring its focus on innovation.
The company offers a wide portfolio of solutions, including turnkey horticultural projects like integrated packhouses, climate-controlled greenhouses, automation systems, and drip irrigation to enhance crop yield and quality. It also facilitates organic adoption and certification under NPOP and PGS, helping farmers transition to sustainable practices. Through FPO management, skill development programs, seminars, workshops, and exposure visits, Sheel Biotech empowers farmers and agripreneurs with knowledge and market linkages. As of September 12, 2025, the company has 160 permanent employees, strengthening its position as a trusted partner in modern agriculture.
Sheel Biotech IPO Company Financial Report
Amount ₹ in Crores
Period Ended Revenue Expense PAT Assets 2023 ₹80.19 ₹73.82 ₹5.08 ₹93.89 2024 ₹92.55 ₹80.29 ₹10.51 ₹105.95 May 2024 ₹3.99 ₹3.34 ₹0.48 ₹105.98
Sheel Biotech IPO Valuation – FY2024
Check Sheel Biotech IPO valuations details like Earnings Per Share (EPS), Price/Earnings P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
KPI Values ROE: 14.45% ROCE: 16.47% EBITDA Margin: 15.66% PAT Margin: 11.39% Debt to equity ratio: 0.32 Earning Per Share (EPS): ₹7.25 (Basic) Price/Earnings P/E Ratio: N/A Return on Net Worth (RoNW): 14.45% Net Asset Value (NAV): ₹50.15
Peer Group Comparison
Company EPS PE Ratio RoNW % NAV Income Jain Irrigation System Limited 0.83 108.98 1.18% 72.42 55.55 Cr.
IPO Lead Managers aka Merchant Bankers
- Narnolia Financial Services Ltd.
IPO Registrar
Skyline Financial Services Pvt. Ltd.
Phone: 02228511022
Email: compliances@skylinerta.com
Website: https://www.skylinerta.com/ipo.php
Company Address
Sheel Biotech Ltd.
8 Balaji Estates, 2nd Floor, Block-C,
Guru Ravidas Marg, Kalkaji
South Delhi, New Delhi, 110019
Phone: +91 88511 – 8980
Email: compliance@sheelbiotech.com
Website: http://www.sheelbiotech.com/